Literature DB >> 14976098

Systematic review of prevalence of aspirin induced asthma and its implications for clinical practice.

Christine Jenkins1, John Costello, Linda Hodge.   

Abstract

OBJECTIVE: To reassess the prevalence of aspirin induced asthma and other issues related to the syndrome. DATA SOURCES: Biosis, SciSearch (1990 to March 2002), Embase (1974 to March 2002), Medline (1966 to March 2002), Toxline, Derwent Drug File (1964 to March 2002), Conference Papers Index and Inside Conferences, Int'l Pharmaceutical Abstracts, Pharma-Online (1978 to March 2002). SELECTION CRITERIA: Study type, patient population, and outcome measures. Review was restricted to respiratory responses to analgesics available without prescription.
RESULTS: The prevalence of aspirin induced asthma was highest when determined by oral provocation testing (adults 21%, 95% confidence interval 14% to 29%; children 5%, 0% to 14%) than by verbal history (adults 3%, 2% to 4%; children 2%, 1% to 3%). Cross sensitivity to doses of over the counter non-steroidal anti-inflammatory drugs was present in most patients with aspirin induced asthma: ibuprofen, 98%; naproxen, 100%; and diclofenac, 93%. The incidence of cross sensitivity to paracetamol among such patients was only 7%.
CONCLUSIONS: Aspirin induced asthma in adults is more prevalent than previously suggested. When there is a clinical necessity to use aspirin or a non-steroidal anti-inflammatory drug and there is uncertainty about safety, oral provocation testing should be performed.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14976098      PMCID: PMC344260          DOI: 10.1136/bmj.328.7437.434

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


  33 in total

1.  Long-term prognosis of near-fatal asthma. A 6-year follow-up study of 145 asthmatic patients who underwent mechanical ventilation for a near-fatal attack of asthma.

Authors:  C H Marquette; F Saulnier; O Leroy; B Wallaert; C Chopin; J M Demarcq; A Durocher; A B Tonnel
Journal:  Am Rev Respir Dis       Date:  1992-07

2.  Rates of sensitivity reactions to aspirin: problems in interpreting the data.

Authors:  C K Kwoh; A R Feinstein
Journal:  Clin Pharmacol Ther       Date:  1986-11       Impact factor: 6.875

3.  Aspirin intolerance in chronic childhood asthma: Detected by oral challenge.

Authors:  G S Rachelefsky; A Coulson; S C Siegel; E R Stiehm
Journal:  Pediatrics       Date:  1975-09       Impact factor: 7.124

4.  Asthmatic attacks induced in aspirin-sensitive patients by diclofenac and naproxen.

Authors:  A Szczeklik; R J Gryglewski; G Czerniawska-Mysik; R Pieton
Journal:  Br Med J       Date:  1977-07-23

5.  Oral and bronchial provocation tests with aspirin for diagnosis of aspirin-induced asthma.

Authors:  E Nizankowska; A Bestyńska-Krypel; A Cmiel; A Szczeklik
Journal:  Eur Respir J       Date:  2000-05       Impact factor: 16.671

6.  Diagnosis, prevention, and treatment of adverse reactions to aspirin and nonsteroidal anti-inflammatory drugs.

Authors:  D D Stevenson
Journal:  J Allergy Clin Immunol       Date:  1984-10       Impact factor: 10.793

7.  Role of acetyl salicylic acid and sodium metabisulfite in chronic childhood asthma.

Authors:  S J Towns; C M Mellis
Journal:  Pediatrics       Date:  1984-05       Impact factor: 7.124

8.  Oral challenge with alternative nonsteroidal antiinflammatory drugs (NSAIDs) and paracetamol in patients intolerant to these agents.

Authors:  M Ispano; A Fontana; J Scibilia; C Ortolani
Journal:  Drugs       Date:  1993       Impact factor: 9.546

9.  Oral acetylsalicylic acid (aspirin) challenge in asthmatic children.

Authors:  J F Schuhl; J G Pereyra
Journal:  Clin Allergy       Date:  1979-01

10.  Adverse reaction of acetaminophen as an alternative analgesic in A.A.S. Triad.

Authors:  P G Barles; F Duce García; J R Portillo Olmo; J Pérez Aznar; J L Escuer Alarma
Journal:  Allergol Immunopathol (Madr)       Date:  1988 Sep-Oct       Impact factor: 1.667

View more
  73 in total

1.  Aspirin induced asthma: effect size needs to be clarified.

Authors:  Robert D Southward
Journal:  BMJ       Date:  2004-05-01

2.  Aspirin induced asthma: clinical relevance of finding was not explained.

Authors:  Indu Sivanandan; Stephen M Robinson
Journal:  BMJ       Date:  2004-05-01

3.  ADAM33 polymorphisms are associated with aspirin-intolerant asthma in the Japanese population.

Authors:  Takuro Sakagami; Nobuyoshi Jinnai; Toshiaki Nakajima; Takashi Sekigawa; Takashi Hasegawa; Eiichi Suzuki; Ituro Inoue; Fumitake Gejyo
Journal:  J Hum Genet       Date:  2006-10-24       Impact factor: 3.172

Review 4.  Update on aspirin desensitization for chronic rhinosinusitis with polyps in aspirin-exacerbated respiratory disease (AERD).

Authors:  Ronald A Simon; Kristen M Dazy; Jeremy D Waldram
Journal:  Curr Allergy Asthma Rep       Date:  2015-03       Impact factor: 4.806

5.  Aspirin and acetaminophen: should they be available over the counter?

Authors:  Kay Brune; Burkhard Hinz; Ivan Otterness
Journal:  Curr Rheumatol Rep       Date:  2009-02       Impact factor: 4.592

6.  Low prevalence of hypersensitivity to nonsteroidal anti-inflammatory drugs in Chinese patients with chronic rhinosinusitis.

Authors:  Yingshen Lu; Shuai Li; Lijuan Song; Hui Jin; Yanmei Li; Nanshan Zhong; Xiaowen Zhang
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-02-13       Impact factor: 2.503

7.  Nonsteroidal anti-inflammatory drug administration in children with history of wheeze.

Authors:  Kendra Sih; Ran D Goldman
Journal:  Can Fam Physician       Date:  2016-08       Impact factor: 3.275

Review 8.  Aspirin resistance and other aspirin-related concerns.

Authors:  Gaoyu Cai; Weijun Zhou; Ya Lu; Peili Chen; Zhongjiao Lu; Yi Fu
Journal:  Neurol Sci       Date:  2015-11-14       Impact factor: 3.307

9.  Aspirin-exacerbated asthma.

Authors:  Mathew Varghese; Richard F Lockey
Journal:  Allergy Asthma Clin Immunol       Date:  2008-06-15       Impact factor: 3.406

10.  Airway responsiveness to inhaled aspirin is influenced by airway hyperresponsiveness in asthmatic patients.

Authors:  Sungsoo Kim; Inseon S Choi; Yeon-Joo Kim; Chang-Seong Kim; Eui-Ryoung Han; Dong-Jin Park; Dae-Eun Kim
Journal:  Korean J Intern Med       Date:  2010-08-31       Impact factor: 3.165

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.